Drug Makers Issue Record Number of 340B Refunds in 2023, Merck First to Refund in 2024

Drugmakers issued a record 41 refunds to 340B covered entities in 2023.
Drugmakers issued a record 41 refunds to 340B covered entities in 2023. And Merck is the first to announce it [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Takeda to Expand 340B Contract Pharmacy Restrictions

Takeda 340B
Japanese drugmaker Takeda announced its cancer medication Ninlaro will be subject to its 340B contract pharmacy policy.
Just days prior to implementing its first contract pharmacy restrictions, Japanese pharmaceutical giant Takeda yesterday announced it will increase the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Three More States Introduce 340B Contract Pharmacy Protection Bills

Sen. Louise Lucas
Virginia state Sen. Louise Lucas this month introduced a 340B contract pharmacy bill. Influential state senators in Kentucky and Florida also recently introduced similar bills.
Influential state senators in Kentucky, Virginia, and Florida have introduced bills recently that would prohibit drug manufacturer restrictions on 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

2024 340B Contract Pharmacy Outlook: Expect More State Than Federal Action, Say Attorneys and Lobbyists

US Eighth Circuit Court of Appeals building
A decision upholding Arkansas' state contract pharmacy law from the U.S. 8th Circuit Court of Appeals could cause more states to push similar laws, attorneys and lobbyists said.
Amid expected congressional gridlock, there is a much higher likelihood of state legislative action on 340B contract pharmacies than federal [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Novo Says Arkansas Agreement ‘Preserves It’s Position’; More Manufacturer Deals in the Works

Arkansas Insurance Department office sign
The Arkansas Insurance Department will imminently enforce a state 340B contract pharmacy law following a key federal appeals court decision.
Drugmaker Novo Nordisk’s deal with Arkansas restoring 340B discounts in the contract pharmacy setting until a coming appeals court ruling, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

2024 Congressional 340B Outlook: Overhaul Unlikely Without Major Legal Developments, Senate Deal

US Capitol
Congress is unlikely to pass a 340B program overhaul in 2024 unless there is unexpected pressure from appellate court decisions or a Senate "group of 6" breakthrough, attorneys and lobbyists said.
In 2024, congressional gridlock and election year dynamics will likely slow momentum on any comprehensive 340B program reform package, lobbyists [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Gilead Expands 340B Reporting to Wholly Owned Contract Pharmacies

Gilead exterior office sign
Gilead Sciences will expand its data reporting requirements for 340B pricing on branded hepatitis C products to contract pharmacies wholly owned by covered entities.
Drugmaker Gilead Sciences will expand its data reporting requirements for 340B pricing on branded hepatitis C products to contract pharmacies [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

J&J Offers Refunds on Blockbuster Drug, Other Manufacturers Update NDCs

Johnson & Johnson building-mounted sign
J&J will offer refunds to 340B providers related to the purchases of four of its drugs, including top-selling Stelara.
Drugmaker Johnson & Johnson will offer refunds to 340B providers related to the purchases of four of its drugs, including [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

2023 Contract Pharmacy Developments: Surging Restrictions, State Law Legal Battles

In 2023, Arkansas became the first state to move to enforce a 340B contract pharmacy law as manufacturer restrictions continued to increase.
In 2023, the battle over the use of contract pharmacy arrangements by 340B providers was marked by increasing drugmaker restrictions, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Louisiana, Health Centers Seek Dismissal of Contract Pharmacy Law Challenge

AstraZeneca headquarters
The state of Louisiana and a coalition of community health centers urged a federal district court to dismiss AstraZeneca's lawsuit against a state contract pharmacy law.
Attorneys representing the state of Louisiana and 340B providers urged a federal judge to dismiss AstraZeneca’s lawsuit against Louisiana’s contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live